Skip to main content

Table 4 Indications associated with the first antidepressant prescription

From: Secondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch database

IndicationAges 5–11 (n = 2330)Ages 12–17 (n = 30,701)SSRI (n = 22,130)TCA (n = 10,489)Any antidepressant ages 5–17 (n = 33,031)
Any of the pre-specified indications998 (42.8%)16,974 (55.3%)15,295 (69.1%)2463 (23.5%)17,972 (54.4%)
Anxiety136 (5.8%)4019 (13.1%)3601 (16.3%)508 (4.8%)4155 (12.6%)
Attention deficit hyperactivity disorder< 1061 (0.2%)50 (0.2%)14 (0.1%)66 (0.2%)
Autism206 (8.8%)1020 (3.3%)1127 (5.1%)90 (0.9%)1226 (3.7%)
Depression72 (3.1%)12,558 (40.9%)11,537 (52.1%)936 (8.9%)12,630 (38.2%)
Enuresis642 (27.6%)308 (1.0%)73 (0.3%)877 (8.4%)950 (2.9%)
Neuropathic pain< 10104 (0.3%)< 10107 (1.0%)113 (0.3%)
Obsessive compulsive disorder53 (2.3%)751 (2.4%)774 (3.5%)28 (0.3%)804 (2.4%)
Phobias< 10260 (0.8%)222 (1%)40 (0.4%)268 (0.8%)
Self-harm10 (0.4%)2948 (9.6%)2715 (12.3%)190 (1.8%)2958 (9.0%)
  1. Includes indications recorded less than 1 year before or 6 months after the first antidepressant prescription. Individuals may be included in both SSRI and TCA categories and may have records of more than one indication. Counts less than 10 have been masked
  2. SSRI selective serotonin reuptake inhibitor, TCA tricyclic and related antidepressant, n number